• ClinicalTrials.gov – English and Spanish www.clinicaltrials.govTelephone: 1-800-411-1222
• Food and Drug Administration (FDA) www.fda.govTelephone: 1-888-463-6332

Nexus Clinical Research is structured for rapid start-up timelines.
Typical activation benchmarks include:

• Regulatory submissions: 3–5 business days

• Budget & contract turnaround: 5–7 business days

• Rapid feasibility completion

Our experienced regulatory and operations team ensures efficient study activation while maintaining strict compliance standards.

Clinical trial volunteers participate in the development of medical therapies that may offer better treatments and even cures for life-threatening and chronic diseases. Possible benefits for volunteers include:

• The opportunity to play an active role in your health care and gain a greater understanding of your disease or medical condition.
• Health assessments related to the study from our board-certified specialists.
• Study related medication and lab assessments at no cost.
• Access to promising new treatments often not available outside the clinical trial setting.
• Help others by contributing to medical research.

You should obtain as much information as possible before deciding to participate in a clinical trial. You should also feel comfortable asking the following questions and discussing any issues or concerns with your clinical research team members:

• What is the purpose of the clinical trial?
• Why do researchers believe the new treatment being tested may be effective?
• Has the treatment been tested before?
• What kinds of tests and treatments are involved?
• What are the possible study side effects and benefits?
• How might this trial affect my daily life?
• How long will the trial last?
• Will hospitalization be required?
• Who will pay for the treatment?
• Will I be reimbursed for expenses?

Through our investigator network, Nexus Clinical Research has participated in 50+ completed clinical studies across multiple therapeutic areas. Our team has experience working with sponsors, CROs, and academic research organizations on a wide variety of protocols.

Our team follows strict GCP and HIPAA compliance standards. Staff members receive ongoing training, and our processes are designed to ensure accurate documentation, timely query resolution, and proactive monitoring of protocol adherence.

Sponsors choose Nexus because of our combination of:

• Access to a large and diverse patient population

• Engaged and experienced investigators

• Efficient study start-up timelines

• Strong regulatory oversight

• Reliable patient enrollment and retention strategies

Our goal is to deliver high-quality data while helping sponsors move their studies forward efficiently.

Our site has access to a growing database of more than 20,000 pre-identified participants, supported by strong physician referral networks and targeted recruitment strategies. In addition, our location in South Florida provides access to a diverse patient population, including a large bilingual Hispanic community.

Our modern clinical research center includes:

• Multiple dedicated exam rooms

• Secure investigational product storage with temperature monitoring

• Laboratory space for specimen processing

• Private monitoring rooms for sponsor and CRO visits

• Secure systems for data handling and regulatory documentation

This infrastructure allows us to support complex study protocols while maintaining a comfortable participant experience.

Yes. Sponsors and CROs may contact our team to request additional materials such as:

• Site capabilities overview

• Principal Investigator CVs

• Recruitment strategy details

• Feasibility assessments

Our team is available to discuss upcoming study opportunities and potential collaborations.

Nexus Clinical Research operates as a multi-specialty clinical trial site with experienced investigators in neurology, pulmonology, endocrinology, dermatology, cardiology, and internal medicine. This broad coverage allows our team to support a wide range of protocols and indications across Phase I–IV studies.